Monocyte Count Predicts Lung Disease Risk in COVID-19 Patients
University of Virginia Health System
A simple blood test result can inform clinicians which patients with severe COVID-19 will develop long-haul lung problems
Results reinforce the need to include Black and Hispanic people in cancer trials to deliver equitable patient care
The Society aims to reduce lung cancer deaths with updated screening recommendations